Simplex Trading
OVID icon

Simplex Trading’s Ovid Therapeutics OVID Stock Holding History

Simplex Trading’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538 Sell
200
-100
-33% -$258 ﹤0.01% 8944
2026
Q1 		$666 Sell
300
-6,800
-96% -$12.2K ﹤0.01% 8682
2025
Q4 		$11.6K Sell
7,100
-147,100
-95% -$227K ﹤0.01% 6898
2025
Q3 		$200K Buy
+154,200
New +$134K ﹤0.01% 4935
2024
Q4 		– Sell
-10,900
Closed -$12K – 9334
2024
Q3 		$12K Sell
10,900
-100
-0.9% -$104 ﹤0.01% 7080
2024
Q2 		$8K Buy
+11,000
New +$30.6K ﹤0.01% 7601
2023
Q3 		– Sell
-1,500
Closed -$4K – 9515
2023
Q2 		$4K Hold
1,500
– – ﹤0.01% 8074
2023
Q1 		$3K Buy
+1,500
New +$3.56K ﹤0.01% 8333
2021
Q4 		– Sell
-276,600
Closed -$1.09M – 11167
2021
Q3 		$1.09M Hold
276,600
– – ﹤0.01% 2929
2021
Q2 		$1.08M Buy
276,600
+273,667
+9,331% +$1.08M ﹤0.01% 2996
2021
Q1 		$1.18M Buy
2,933
+2,657
+963% +$8.82K ﹤0.01% 2208
2020
Q4 		$63K Buy
276
+230
+500% +$1.07K ﹤0.01% 5929
2020
Q3 		$26K Sell
46
-6
-12% -$40 ﹤0.01% 6187
2020
Q2 		$38K Buy
+52
New +$243 ﹤0.01% 5723

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Simplex Trading's OVID Position: Q2 2026 in Review

Simplex Trading sold out of Ovid Therapeutics (OVID) in Q2 2026, closing a stake of 3,674 shares — an estimated $9.48K sold.

Simplex Trading first reported a position in OVID in Q4 2020 and held it in 11 quarters. The position peaked at $503K in Q3 2025. 131 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Simplex Trading reported no remaining Ovid Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 3,674 Ovid Therapeutics shares in Q2 2026, an estimated $9.48K.
  • Simplex Trading first reported a position in Ovid Therapeutics in Q4 2020 and held it in 11 quarters.
  • Simplex Trading's Ovid Therapeutics position peaked at $503K in Q3 2025.
  • 131 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.